
Eli Lilly Kinsale Pharmaceutical Manufacturing Facility
Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in December 2006.
Medical Air Technology (MAT) specialises in the three main ‘Cs’ required by the pharmaceutical and bio-technology industries: cleanrooms, containment suites and clean air solutions.
MAT has been synonymous with utilising clean air engineering to create safe, clean and productive working environments for over 26 years, specialising in designing and building a multitude of highly successful cleanrooms, containment suites and cGMP-compliant facilities.
We offer within one independent organisation a single point of responsibility and accountability for the specialist elements required by today’s pharmaceutical and bio-technology organisations. MAT consults, designs, constructs, commissions and validates to the highest of international standards required within this very demanding marketplace.
MAT engineers manage a variety of cleanroom, containment and clean air projects through their varied stages, from inception to completion, covering such areas as:
MAT is a well-respected organisation with a wealth of experience and expertise, and has earned a reputation for exceptionally high-quality products and services to meet the exacting standards required for the pharmaceutical, medical and wider industrial markets.
We have the process and manufacturing knowledge to understand and appreciate the onerous science involved behind the project and the true requirements the user sees within their project. This has been fundamental to our success in providing international solutions.
Our unique service is headquartered in Oldham, Manchester, and covers the UK and global market from this and a number of satellite locations. The project range spans the pharmaceutical and bio-technology markets and encompasses:
MAT often finds itself the ‘interpreter’ of the user’s requirements for a facility, and then supplies the most cost-effective and efficient solution for the industrialisation of the requirement. This ranges from large to small projects, and for users through to main contractors, at many different values and contractual relationships.
Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in December 2006.
Brecon Pharmaceuticals Ltd, a subsidiary of AmerisourceBergen, is based in the Wye Valley Business Park near Hay-on-Wye
The National Biomanufacturing Centre (NBC) is a biotech plant constructed on a 60,000ft² plot on the Estuary Commer
Avecia Biotechnology announced a $100m investment in a new advanced centre for biologics manufacture in Billingham,
Pfizer's Biotechnology Campus in Clondalkin, Ireland, was opened in September 2005.
Medical Air Technology (MAT) has undertaken the design, construction, installation and validation of four turnkey CL3 laboratory suites for Mater Dei Hospital in Malta. This prestigious new acute hospital is also used as a teaching facility by the neighbouring University of Malta and is a flagshi
31 May 2010Medical Air Technology (MAT) is renowned within the UK and Europe for the provision of integrated facilities including the design, manufacture, installation, commissioning and validation of clean air systems. MAT is pleased to announce the appointment of Steve Stott to the new role of s
16 February 2010Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology